Company Filing History:
Years Active: 2023
Title: Chuck Hannum: Innovator in Cancer Treatment
Introduction
Chuck Hannum is a prominent inventor based in San Jose, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic antibodies.
Latest Patents
Hannum holds a patent for CRTAM antibodies and methods of treating cancer. This patent discloses antibodies directed against CRTAM, nucleic acids encoding such antibodies, and methods for preparing anti-CRTAM antibodies. The patent also outlines methods for treating various human cancers, including small cell lung cancer, non-small cell lung cancer, melanoma, breast cancer, colorectal cancer, and many others.
Career Highlights
Chuck Hannum has established himself as a key figure in the biotechnology sector. His work at Oxford Biotherapeutics Ltd. has been instrumental in advancing cancer therapies. His innovative approaches have the potential to improve treatment outcomes for patients suffering from various types of cancer.
Collaborations
Hannum collaborates with talented professionals in the field, including Arnima Bisht and Rachel L Dusek. These partnerships enhance the research and development efforts at Oxford Biotherapeutics Ltd.
Conclusion
Chuck Hannum's contributions to cancer treatment through his patented innovations highlight his dedication to improving patient care. His work continues to inspire advancements in the biotechnology industry.